Annual Accounts Receivable
$108.29M$188.96M-63.57%
Summary
- Current Value
- As of today, NVAX annual accounts receivable is $108.29M, down -63.57% on
- Historical Performance
- NVAX annual accounts receivable is down -76.20% over the past 3 years, and up +1343.80% over the past 5 years
- All-Time High Comparison
- NVAX annual accounts receivable is currently -76.20% below its historical high of $454.99M set on
- 3-Year Low Comparison
- NVAX annual accounts receivable is +31.45% above its 3-year low of $82.38M reached on an earlier date
- Sector Comparison
- NVAX annual accounts receivable is higher than 72.92% of companies in Healthcare sector
Annual Accounts Receivable Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Accounts Receivable | $108.29M | -63.6% | -76.2% | +1343.8% | +10000.0% | |
| Quarterly Accounts Receivable | $34.17M | -64.0% | -69.4% | +111.2% | +5605.2% | |
| Price | $7.78 | -9.0% | -36.7% | -93.9% | -84.5% | |
| Annual Accounts Payable | $41.58M | -68.7% | -67.3% | +1328.8% | +1881.8% | |
| Annual Current Assets | $1.13B | -1.3% | -47.6% | +1060.9% | +2436.8% | |
| Annual Revenue | $682.16M | -30.6% | -40.5% | +3555.3% | +10000.0% | |
| Annual Net Income | -$187.50M | +65.6% | +89.3% | -41.3% | -388.6% | |
| Annual Cash & Cash Equivalents | $933.74M | +61.3% | -38.8% | +1041.9% | +2074.0% |
Annual Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $297.24M | -63.6% | |
| 5Y | $454.99M | -76.2% | |
| All | $454.99M | -76.2% |
Annual Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $82.38M | N/A | +31.4% |
| 5Y | $82.38M | +31.4% | |
| All | $54.00K | >+9999.0% |
Annual Accounts Receivable History
FAQ
What is the current annual accounts receivable of NVAX?
As of today, NVAX annual accounts receivable is $108.29M
What is 1-year change in NVAX annual accounts receivable?
NVAX annual accounts receivable is down -63.57% year-over-year
What is 3-year change in NVAX annual accounts receivable?
NVAX annual accounts receivable is down -76.20% over the past 3 years
How far is NVAX annual accounts receivable from its all-time high?
NVAX annual accounts receivable is currently -76.20% below its historical high of $454.99M set on December 31, 2021
How does NVAX annual accounts receivable rank versus sector peers?
NVAX annual accounts receivable is higher than 72.92% of companies in Healthcare sector
When is NVAX next annual earnings release?
The next annual earnings release for NVAX is on
Quarterly Accounts Receivable
$34.17M$192.22M-84.91%
Summary
- Current Value
- As of today, NVAX quarterly accounts receivable is $34.17M, down -84.91% on
- Historical Performance
- NVAX quarterly accounts receivable is down -64.01% year-over-year, and down -69.39% over the past 3 years
- All-Time High Comparison
- NVAX quarterly accounts receivable is currently -92.85% below its historical high of $478.16M set on
- 3-Year Low Comparison
- NVAX quarterly accounts receivable is +59.84% above its 3-year low of $21.38M reached on
- Sector Comparison
- NVAX quarterly accounts receivable is higher than 60.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Accounts Receivable | $34.17M | -84.9% | -64.0% | -69.4% | +111.2% | |
| Annual Accounts Receivable | $108.29M | – | -63.6% | -76.2% | +1343.8% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| Quarterly Accounts Payable | $15.23M | -69.9% | -73.5% | -89.5% | +0.9% | |
| Quarterly Current Assets | $974.59M | +6.0% | -11.7% | -44.6% | +45.2% | |
| Quarterly Revenue | $70.45M | -70.5% | -16.6% | -90.4% | -55.1% | |
| Quarterly Net Income | -$202.38M | -290.0% | -66.8% | -20.0% | -2.6% | |
| Quarterly Cash & Cash Equivalents | $773.71M | +24.2% | -15.9% | -40.1% | +35.5% |
Quarterly Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $226.40M | -84.9% | |
| 3Y | $394.89M | -91.3% | |
| 5Y | $478.16M | -92.8% | |
| All | $478.16M | -92.8% |
Quarterly Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $34.17M | at low | |
| 3Y | $21.38M | +59.8% | |
| 5Y | $21.38M | +59.8% | |
| All | $0.00 | N/A |
Quarterly Accounts Receivable History
FAQ
What is the current quarterly accounts receivable of NVAX?
As of today, NVAX quarterly accounts receivable is $34.17M
What is NVAX quarterly accounts receivable most recent change?
NVAX quarterly accounts receivable was down -84.91% on September 30, 2025
What is 1-year change in NVAX quarterly accounts receivable?
NVAX quarterly accounts receivable is down -64.01% year-over-year
How far is NVAX quarterly accounts receivable from its all-time high?
NVAX quarterly accounts receivable is currently -92.85% below its historical high of $478.16M set on March 31, 2022
How does NVAX quarterly accounts receivable rank versus sector peers?
NVAX quarterly accounts receivable is higher than 60.82% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax